Ironwood Pharmaceuticals, Inc.
IRWD
$1.55
-$0.06-3.73%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -185.59% | 96.93% | 100.09% | 99.74% | 101.00% |
| Total Depreciation and Amortization | 14.72% | 31.91% | 53.08% | 73.77% | 61.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.47% | -92.13% | -91.45% | -91.42% | -90.97% |
| Change in Net Operating Assets | -270.88% | -51.68% | -100.21% | 14.04% | 41.98% |
| Cash from Operations | -79.57% | -47.03% | -43.55% | -45.25% | -44.29% |
| Capital Expenditure | 87.31% | 67.99% | 47.99% | -908.57% | -642.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 99.61% | 97.34% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 99.82% | 99.99% | 99.99% | 99.58% | 97.30% |
| Total Debt Issued | -100.00% | -62.50% | -62.50% | -62.50% | -62.50% |
| Total Debt Repaid | 87.69% | -92.00% | -165.00% | -266.67% | -- |
| Issuance of Common Stock | -97.49% | -92.30% | 73.24% | 44.62% | 32.07% |
| Repurchase of Common Stock | 100.00% | 80.36% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 91.65% | 92.31% | 92.31% | -1,166.14% | -1,072.20% |
| Cash from Financing | 78.02% | -135.48% | -138.60% | -143.22% | -146.92% |
| Foreign Exchange rate Adjustments | -723.75% | -117.24% | 39.62% | -3,333.33% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 82.18% | 97.90% | 99.36% | 94.99% | 78.42% |